APO Research
Talk to an analyst

APO RESEARCH · REPORT

I.V. (Intravenous Fluid) Bags

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global I.V. (Intravenous Fluid) Bags Market Outlook and Growth Opportunities 2026

25 December 2025190 pages

Choose your research edition.

Industry ResearchI.V. (Intravenous Fluid) Bags Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal I.V. (Intravenous Fluid) Bags Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal I.V. (Intravenous Fluid) Bags Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal I.V. (Intravenous Fluid) Bags Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal I.V. (Intravenous Fluid) Bags Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global I.V. (Intravenous Fluid) Bags market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for I.V. (Intravenous Fluid) Bags is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for I.V. (Intravenous Fluid) Bags is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for I.V. (Intravenous Fluid) Bags is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the I.V. (Intravenous Fluid) Bags market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the I.V. (Intravenous Fluid) Bags market include Amcor, Baxter, Fresenius Kabi, Hospira (Pfizer), ICU Medical, Inc., JW Lifescience Corporation, Otsuka Pharmaceutical, SIPPEX and Wihuri Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global I.V. (Intravenous Fluid) Bags market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of I.V. (Intravenous Fluid) Bags and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents I.V. (Intravenous Fluid) Bags sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the I.V. (Intravenous Fluid) Bags market size, projected growth trends, production technologies, key applications, and end-use industries.

I.V. (Intravenous Fluid) Bags Segment by Company

Amcor

Baxter

Fresenius Kabi

Hospira (Pfizer)

ICU Medical, Inc.

JW Lifescience Corporation

Otsuka Pharmaceutical

SIPPEX

Wihuri Group

B. Braun

I.V. (Intravenous Fluid) Bags Segment by Type

Polyolefin IV Bags

PVC (polyvinyl chloride) IV Bags

Others

I.V. (Intravenous Fluid) Bags Segment by Application

Veterinary Medicine

Drug Delivery

Healthcare

I.V. (Intravenous Fluid) Bags Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global I.V. (Intravenous Fluid) Bags status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions I.V. (Intravenous Fluid) Bags market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify I.V. (Intravenous Fluid) Bags significant trends, drivers, influence factors in global and regions.

6. To analyze I.V. (Intravenous Fluid) Bags competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global I.V. (Intravenous Fluid) Bags market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of I.V. (Intravenous Fluid) Bags and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of I.V. (Intravenous Fluid) Bags.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the I.V. (Intravenous Fluid) Bags market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global I.V. (Intravenous Fluid) Bags industry.

Chapter 3: Detailed analysis of I.V. (Intravenous Fluid) Bags manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of I.V. (Intravenous Fluid) Bags in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of I.V. (Intravenous Fluid) Bags in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. I.V. (Intravenous Fluid) Bags Industry Trends Table 2. I.V. (Intravenous Fluid) Bags Industry Drivers Table 3. I.V. (Intravenous Fluid) Bags Industry Opportunities and Challenges Table 4. I.V. (Intravenous Fluid) Bags Industry Restraints Table 5. Global I.V. (Intravenous Fluid) Bags Revenue by Company (US$ Million) & (2021-2026) Table 6. Global I.V. (Intravenous Fluid) Bags Revenue Share by Company (2021-2026) Table 7. Global I.V. (Intravenous Fluid) Bags Sales Volume by Company (Units) & (2021-2026) Table 8. Global I.V. (Intravenous Fluid) Bags Sales Volume Share by Company (2021-2026) Table 9. Global I.V. (Intravenous Fluid) Bags Average Price (US$/Unit) of Company (2021-2026) Table 10. Global I.V. (Intravenous Fluid) Bags Company Ranking, (2024-2026) & (USD Million) Table 11. Global I.V. (Intravenous Fluid) Bags Key Company Manufacturing Base & Headquarters Table 12. Global I.V. (Intravenous Fluid) Bags Company, Product Type & Application Table 13. Global I.V. (Intravenous Fluid) Bags Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global I.V. (Intravenous Fluid) Bags by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Polyolefin IV Bags Table 18. Significant Companies of PVC (polyvinyl chloride) IV Bags Table 19. Significant Companies of Others Table 20. Global I.V. (Intravenous Fluid) Bags Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 21. Global I.V. (Intravenous Fluid) Bags Sales Volume by Type (2021-2026) & (Units) Table 22. Global I.V. (Intravenous Fluid) Bags Sales Volume by Type (2027-2032) & (Units) Table 23. Global I.V. (Intravenous Fluid) Bags Sales Volume Share by Type (2021-2026) Table 24. Global I.V. (Intravenous Fluid) Bags Sales Volume Share by Type (2027-2032) Table 25. Global I.V. (Intravenous Fluid) Bags Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global I.V. (Intravenous Fluid) Bags Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global I.V. (Intravenous Fluid) Bags Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global I.V. (Intravenous Fluid) Bags Sales Value Share by Type (2021-2026) Table 29. Global I.V. (Intravenous Fluid) Bags Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Veterinary Medicine Table 31. Significant Companies of Drug Delivery Table 32. Significant Companies of Healthcare Table 33. Global I.V. (Intravenous Fluid) Bags Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 34. Global I.V. (Intravenous Fluid) Bags Sales Volume by Application (2021-2026) & (Units) Table 35. Global I.V. (Intravenous Fluid) Bags Sales Volume by Application (2027-2032) & (Units) Table 36. Global I.V. (Intravenous Fluid) Bags Sales Volume Share by Application (2021-2026) Table 37. Global I.V. (Intravenous Fluid) Bags Sales Volume Share by Application (2027-2032) Table 38. Global I.V. (Intravenous Fluid) Bags Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global I.V. (Intravenous Fluid) Bags Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global I.V. (Intravenous Fluid) Bags Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global I.V. (Intravenous Fluid) Bags Sales Value Share by Application (2021-2026) Table 42. Global I.V. (Intravenous Fluid) Bags Sales Value Share by Application (2027-2032) Table 43. Global I.V. (Intravenous Fluid) Bags Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 44. Global I.V. (Intravenous Fluid) Bags Sales by Region (2021-2026) & (Units) Table 45. Global I.V. (Intravenous Fluid) Bags Sales Market Share by Region (2021-2026) Table 46. Global I.V. (Intravenous Fluid) Bags Sales by Region (2027-2032) & (Units) Table 47. Global I.V. (Intravenous Fluid) Bags Sales Market Share by Region (2027-2032) Table 48. Global I.V. (Intravenous Fluid) Bags Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global I.V. (Intravenous Fluid) Bags Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global I.V. (Intravenous Fluid) Bags Sales Value Share by Region (2021-2026) Table 51. Global I.V. (Intravenous Fluid) Bags Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global I.V. (Intravenous Fluid) Bags Sales Value Share by Region (2027-2032) Table 53. Global I.V. (Intravenous Fluid) Bags Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global I.V. (Intravenous Fluid) Bags Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global I.V. (Intravenous Fluid) Bags Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 56. Global I.V. (Intravenous Fluid) Bags Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global I.V. (Intravenous Fluid) Bags Sales by Country (2021-2026) & (Units) Table 58. Global I.V. (Intravenous Fluid) Bags Sales Market Share by Country (2021-2026) Table 59. Global I.V. (Intravenous Fluid) Bags Sales by Country (2027-2032) & (Units) Table 60. Global I.V. (Intravenous Fluid) Bags Sales Market Share by Country (2027-2032) Table 61. Global I.V. (Intravenous Fluid) Bags Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global I.V. (Intravenous Fluid) Bags Sales Value Market Share by Country (2021-2026) Table 63. Global I.V. (Intravenous Fluid) Bags Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global I.V. (Intravenous Fluid) Bags Sales Value Market Share by Country (2027-2032) Table 65. Amcor Company Information Table 66. Amcor Business Overview Table 67. Amcor I.V. (Intravenous Fluid) Bags Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Amcor I.V. (Intravenous Fluid) Bags Product Portfolio Table 69. Amcor Recent Development Table 70. Baxter Company Information Table 71. Baxter Business Overview Table 72. Baxter I.V. (Intravenous Fluid) Bags Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Baxter I.V. (Intravenous Fluid) Bags Product Portfolio Table 74. Baxter Recent Development Table 75. Fresenius Kabi Company Information Table 76. Fresenius Kabi Business Overview Table 77. Fresenius Kabi I.V. (Intravenous Fluid) Bags Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Fresenius Kabi I.V. (Intravenous Fluid) Bags Product Portfolio Table 79. Fresenius Kabi Recent Development Table 80. Hospira (Pfizer) Company Information Table 81. Hospira (Pfizer) Business Overview Table 82. Hospira (Pfizer) I.V. (Intravenous Fluid) Bags Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Hospira (Pfizer) I.V. (Intravenous Fluid) Bags Product Portfolio Table 84. Hospira (Pfizer) Recent Development Table 85. ICU Medical, Inc. Company Information Table 86. ICU Medical, Inc. Business Overview Table 87. ICU Medical, Inc. I.V. (Intravenous Fluid) Bags Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. ICU Medical, Inc. I.V. (Intravenous Fluid) Bags Product Portfolio Table 89. ICU Medical, Inc. Recent Development Table 90. JW Lifescience Corporation Company Information Table 91. JW Lifescience Corporation Business Overview Table 92. JW Lifescience Corporation I.V. (Intravenous Fluid) Bags Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. JW Lifescience Corporation I.V. (Intravenous Fluid) Bags Product Portfolio Table 94. JW Lifescience Corporation Recent Development Table 95. Otsuka Pharmaceutical Company Information Table 96. Otsuka Pharmaceutical Business Overview Table 97. Otsuka Pharmaceutical I.V. (Intravenous Fluid) Bags Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Otsuka Pharmaceutical I.V. (Intravenous Fluid) Bags Product Portfolio Table 99. Otsuka Pharmaceutical Recent Development Table 100. SIPPEX Company Information Table 101. SIPPEX Business Overview Table 102. SIPPEX I.V. (Intravenous Fluid) Bags Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. SIPPEX I.V. (Intravenous Fluid) Bags Product Portfolio Table 104. SIPPEX Recent Development Table 105. Wihuri Group Company Information Table 106. Wihuri Group Business Overview Table 107. Wihuri Group I.V. (Intravenous Fluid) Bags Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Wihuri Group I.V. (Intravenous Fluid) Bags Product Portfolio Table 109. Wihuri Group Recent Development Table 110. B. Braun Company Information Table 111. B. Braun Business Overview Table 112. B. Braun I.V. (Intravenous Fluid) Bags Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. B. Braun I.V. (Intravenous Fluid) Bags Product Portfolio Table 114. B. Braun Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. I.V. (Intravenous Fluid) Bags Distributors List Table 118. I.V. (Intravenous Fluid) Bags Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. I.V. (Intravenous Fluid) Bags Product Image Figure 2. Global I.V. (Intravenous Fluid) Bags Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global I.V. (Intravenous Fluid) Bags Sales Value (2021-2032) & (US$ Million) Figure 4. Global I.V. (Intravenous Fluid) Bags Sales (2021-2032) & (Units) Figure 5. Global I.V. (Intravenous Fluid) Bags Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global I.V. (Intravenous Fluid) Bags Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Polyolefin IV Bags Image Figure 10. PVC (polyvinyl chloride) IV Bags Image Figure 11. Others Image Figure 12. Global I.V. (Intravenous Fluid) Bags Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 13. Global I.V. (Intravenous Fluid) Bags Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global I.V. (Intravenous Fluid) Bags Sales Volume Share by Type (2021-2032) Figure 15. Global I.V. (Intravenous Fluid) Bags Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global I.V. (Intravenous Fluid) Bags Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global I.V. (Intravenous Fluid) Bags Sales Value Share by Type (2021-2032) Figure 18. Veterinary Medicine Image Figure 19. Drug Delivery Image Figure 20. Healthcare Image Figure 21. Global I.V. (Intravenous Fluid) Bags Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 22. Global I.V. (Intravenous Fluid) Bags Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global I.V. (Intravenous Fluid) Bags Sales Volume Share by Application (2021-2032) Figure 24. Global I.V. (Intravenous Fluid) Bags Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global I.V. (Intravenous Fluid) Bags Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global I.V. (Intravenous Fluid) Bags Sales Value Share by Application (2021-2032) Figure 27. Global I.V. (Intravenous Fluid) Bags Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 28. Global I.V. (Intravenous Fluid) Bags Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global I.V. (Intravenous Fluid) Bags Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global I.V. (Intravenous Fluid) Bags Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America I.V. (Intravenous Fluid) Bags Sales Value (2021-2032) & (US$ Million) Figure 32. North America I.V. (Intravenous Fluid) Bags Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe I.V. (Intravenous Fluid) Bags Sales Value (2021-2032) & (US$ Million) Figure 34. Europe I.V. (Intravenous Fluid) Bags Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific I.V. (Intravenous Fluid) Bags Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific I.V. (Intravenous Fluid) Bags Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America I.V. (Intravenous Fluid) Bags Sales Value (2021-2032) & (US$ Million) Figure 38. South America I.V. (Intravenous Fluid) Bags Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa I.V. (Intravenous Fluid) Bags Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa I.V. (Intravenous Fluid) Bags Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. I.V. (Intravenous Fluid) Bags Value Chain Figure 126. Manufacturing Cost Structure Figure 127. I.V. (Intravenous Fluid) Bags Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Polyolefin IV Bags
  • PVC (polyvinyl chloride) IV Bags
  • Others
Applications
  • Veterinary Medicine
  • Drug Delivery
  • Healthcare
Companies covered
  • Amcor
  • Baxter
  • Fresenius Kabi
  • Hospira (Pfizer)
  • ICU Medical, Inc.
  • JW Lifescience Corporation
  • Otsuka Pharmaceutical
  • SIPPEX
  • Wihuri Group
  • B. Braun

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global I.V. (Intravenous Fluid) Bags Sales Value (2021-2032)
  4. 1.2.2 Global I.V. (Intravenous Fluid) Bags Sales Volume (2021-2032)
  5. 1.2.3 Global I.V. (Intravenous Fluid) Bags Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 I.V. (Intravenous Fluid) Bags Market Dynamics
  1. 2.1 I.V. (Intravenous Fluid) Bags Industry Trends
  2. 2.2 I.V. (Intravenous Fluid) Bags Industry Drivers
  3. 2.3 I.V. (Intravenous Fluid) Bags Industry Opportunities and Challenges
  4. 2.4 I.V. (Intravenous Fluid) Bags Industry Restraints
3 I.V. (Intravenous Fluid) Bags Market by Company
  1. 3.1 Global I.V. (Intravenous Fluid) Bags Company Revenue Ranking in 2025
  2. 3.2 Global I.V. (Intravenous Fluid) Bags Revenue by Company (2021-2026)
  3. 3.3 Global I.V. (Intravenous Fluid) Bags Sales Volume by Company (2021-2026)
  4. 3.4 Global I.V. (Intravenous Fluid) Bags Average Price by Company (2021-2026)
  5. 3.5 Global I.V. (Intravenous Fluid) Bags Company Ranking (2024-2026)
  6. 3.6 Global I.V. (Intravenous Fluid) Bags Company Manufacturing Base and Headquarters
  7. 3.7 Global I.V. (Intravenous Fluid) Bags Company Product Type and Application
  8. 3.8 Global I.V. (Intravenous Fluid) Bags Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global I.V. (Intravenous Fluid) Bags Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 I.V. (Intravenous Fluid) Bags Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 I.V. (Intravenous Fluid) Bags Market by Type
  1. 4.1 I.V. (Intravenous Fluid) Bags Type Introduction
  2. 4.1.1 Polyolefin IV Bags
  3. 4.1.2 PVC (polyvinyl chloride) IV Bags
  4. 4.1.3 Others
  5. 4.2 Global I.V. (Intravenous Fluid) Bags Sales Volume by Type
  6. 4.2.1 Global I.V. (Intravenous Fluid) Bags Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global I.V. (Intravenous Fluid) Bags Sales Volume by Type (2021-2032)
  8. 4.2.3 Global I.V. (Intravenous Fluid) Bags Sales Volume Share by Type (2021-2032)
  9. 4.3 Global I.V. (Intravenous Fluid) Bags Sales Value by Type
  10. 4.3.1 Global I.V. (Intravenous Fluid) Bags Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global I.V. (Intravenous Fluid) Bags Sales Value by Type (2021-2032)
  12. 4.3.3 Global I.V. (Intravenous Fluid) Bags Sales Value Share by Type (2021-2032)
5 I.V. (Intravenous Fluid) Bags Market by Application
  1. 5.1 I.V. (Intravenous Fluid) Bags Application Introduction
  2. 5.1.1 Veterinary Medicine
  3. 5.1.2 Drug Delivery
  4. 5.1.3 Healthcare
  5. 5.2 Global I.V. (Intravenous Fluid) Bags Sales Volume by Application
  6. 5.2.1 Global I.V. (Intravenous Fluid) Bags Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global I.V. (Intravenous Fluid) Bags Sales Volume by Application (2021-2032)
  8. 5.2.3 Global I.V. (Intravenous Fluid) Bags Sales Volume Share by Application (2021-2032)
  9. 5.3 Global I.V. (Intravenous Fluid) Bags Sales Value by Application
  10. 5.3.1 Global I.V. (Intravenous Fluid) Bags Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global I.V. (Intravenous Fluid) Bags Sales Value by Application (2021-2032)
  12. 5.3.3 Global I.V. (Intravenous Fluid) Bags Sales Value Share by Application (2021-2032)
6 I.V. (Intravenous Fluid) Bags Regional Sales and Value Analysis
  1. 6.1 Global I.V. (Intravenous Fluid) Bags Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global I.V. (Intravenous Fluid) Bags Sales by Region (2021-2032)
  3. 6.2.1 Global I.V. (Intravenous Fluid) Bags Sales by Region: 2021-2026
  4. 6.2.2 Global I.V. (Intravenous Fluid) Bags Sales by Region (2027-2032)
  5. 6.3 Global I.V. (Intravenous Fluid) Bags Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global I.V. (Intravenous Fluid) Bags Sales Value by Region (2021-2032)
  7. 6.4.1 Global I.V. (Intravenous Fluid) Bags Sales Value by Region: 2021-2026
  8. 6.4.2 Global I.V. (Intravenous Fluid) Bags Sales Value by Region (2027-2032)
  9. 6.5 Global I.V. (Intravenous Fluid) Bags Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America I.V. (Intravenous Fluid) Bags Sales Value (2021-2032)
  12. 6.6.2 North America I.V. (Intravenous Fluid) Bags Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe I.V. (Intravenous Fluid) Bags Sales Value (2021-2032)
  15. 6.7.2 Europe I.V. (Intravenous Fluid) Bags Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific I.V. (Intravenous Fluid) Bags Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific I.V. (Intravenous Fluid) Bags Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America I.V. (Intravenous Fluid) Bags Sales Value (2021-2032)
  21. 6.9.2 South America I.V. (Intravenous Fluid) Bags Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa I.V. (Intravenous Fluid) Bags Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa I.V. (Intravenous Fluid) Bags Sales Value Share by Country, 2025 VS 2032
7 I.V. (Intravenous Fluid) Bags Country-level Sales and Value Analysis
  1. 7.1 Global I.V. (Intravenous Fluid) Bags Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global I.V. (Intravenous Fluid) Bags Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global I.V. (Intravenous Fluid) Bags Sales by Country (2021-2032)
  4. 7.3.1 Global I.V. (Intravenous Fluid) Bags Sales by Country (2021-2026)
  5. 7.3.2 Global I.V. (Intravenous Fluid) Bags Sales by Country (2027-2032)
  6. 7.4 Global I.V. (Intravenous Fluid) Bags Sales Value by Country (2021-2032)
  7. 7.4.1 Global I.V. (Intravenous Fluid) Bags Sales Value by Country (2021-2026)
  8. 7.4.2 Global I.V. (Intravenous Fluid) Bags Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt I.V. (Intravenous Fluid) Bags Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt I.V. (Intravenous Fluid) Bags Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt I.V. (Intravenous Fluid) Bags Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Amcor
  2. 8.1.1 Amcor Company Information
  3. 8.1.2 Amcor Business Overview
  4. 8.1.3 Amcor I.V. (Intravenous Fluid) Bags Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Amcor I.V. (Intravenous Fluid) Bags Product Portfolio
  6. 8.1.5 Amcor Recent Developments
  7. 8.2 Baxter
  8. 8.2.1 Baxter Company Information
  9. 8.2.2 Baxter Business Overview
  10. 8.2.3 Baxter I.V. (Intravenous Fluid) Bags Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Baxter I.V. (Intravenous Fluid) Bags Product Portfolio
  12. 8.2.5 Baxter Recent Developments
  13. 8.3 Fresenius Kabi
  14. 8.3.1 Fresenius Kabi Company Information
  15. 8.3.2 Fresenius Kabi Business Overview
  16. 8.3.3 Fresenius Kabi I.V. (Intravenous Fluid) Bags Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Fresenius Kabi I.V. (Intravenous Fluid) Bags Product Portfolio
  18. 8.3.5 Fresenius Kabi Recent Developments
  19. 8.4 Hospira (Pfizer)
  20. 8.4.1 Hospira (Pfizer) Company Information
  21. 8.4.2 Hospira (Pfizer) Business Overview
  22. 8.4.3 Hospira (Pfizer) I.V. (Intravenous Fluid) Bags Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Hospira (Pfizer) I.V. (Intravenous Fluid) Bags Product Portfolio
  24. 8.4.5 Hospira (Pfizer) Recent Developments
  25. 8.5 ICU Medical, Inc.
  26. 8.5.1 ICU Medical, Inc. Company Information
  27. 8.5.2 ICU Medical, Inc. Business Overview
  28. 8.5.3 ICU Medical, Inc. I.V. (Intravenous Fluid) Bags Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 ICU Medical, Inc. I.V. (Intravenous Fluid) Bags Product Portfolio
  30. 8.5.5 ICU Medical, Inc. Recent Developments
  31. 8.6 JW Lifescience Corporation
  32. 8.6.1 JW Lifescience Corporation Company Information
  33. 8.6.2 JW Lifescience Corporation Business Overview
  34. 8.6.3 JW Lifescience Corporation I.V. (Intravenous Fluid) Bags Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 JW Lifescience Corporation I.V. (Intravenous Fluid) Bags Product Portfolio
  36. 8.6.5 JW Lifescience Corporation Recent Developments
  37. 8.7 Otsuka Pharmaceutical
  38. 8.7.1 Otsuka Pharmaceutical Company Information
  39. 8.7.2 Otsuka Pharmaceutical Business Overview
  40. 8.7.3 Otsuka Pharmaceutical I.V. (Intravenous Fluid) Bags Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Otsuka Pharmaceutical I.V. (Intravenous Fluid) Bags Product Portfolio
  42. 8.7.5 Otsuka Pharmaceutical Recent Developments
  43. 8.8 SIPPEX
  44. 8.8.1 SIPPEX Company Information
  45. 8.8.2 SIPPEX Business Overview
  46. 8.8.3 SIPPEX I.V. (Intravenous Fluid) Bags Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 SIPPEX I.V. (Intravenous Fluid) Bags Product Portfolio
  48. 8.8.5 SIPPEX Recent Developments
  49. 8.9 Wihuri Group
  50. 8.9.1 Wihuri Group Company Information
  51. 8.9.2 Wihuri Group Business Overview
  52. 8.9.3 Wihuri Group I.V. (Intravenous Fluid) Bags Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Wihuri Group I.V. (Intravenous Fluid) Bags Product Portfolio
  54. 8.9.5 Wihuri Group Recent Developments
  55. 8.10 B. Braun
  56. 8.10.1 B. Braun Company Information
  57. 8.10.2 B. Braun Business Overview
  58. 8.10.3 B. Braun I.V. (Intravenous Fluid) Bags Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 B. Braun I.V. (Intravenous Fluid) Bags Product Portfolio
  60. 8.10.5 B. Braun Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 I.V. (Intravenous Fluid) Bags Value Chain Analysis
  2. 9.1.1 I.V. (Intravenous Fluid) Bags Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 I.V. (Intravenous Fluid) Bags Sales Mode & Process
  6. 9.2 I.V. (Intravenous Fluid) Bags Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 I.V. (Intravenous Fluid) Bags Distributors
  9. 9.2.3 I.V. (Intravenous Fluid) Bags Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst